KOSDAQ

Följ
Alteogen executives celebrate shareholder approval for KOSPI listing outside Korea Exchange building, with rising stock charts.
Bild genererad av AI

Major bio firm Alteogen seeks KOSPI listing

Rapporterad av AI Bild genererad av AI

Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.

Korea's main bourse operator, the Korea Exchange (KRX), announced Thursday various plans to strengthen its substantive review for delisting to expedite the exit of troubled companies. The move aligns with the government's efforts to revamp the smaller, venture-heavy KOSDAQ into something resembling the Nasdaq in the United States.

Denna webbplats använder cookies

Vi använder cookies för analys för att förbättra vår webbplats. Läs vår integritetspolicy för mer information.
Avböj